Subhadip Choudhuri
Imran Hussain Chowdhury
Nisha Jain Garg- 1Department of Microbiology and Immunology, University of Texas Medical Branch (UTMB), Galveston, TX, United States
- 2Institute for Human Infections and Immunity, UTMB, Galveston, TX, United States
Innate immune cells play the first line of defense against pathogens. Phagocytosis or invasion by pathogens can affect mitochondrial metabolism in macrophages by diverse mechanisms and shape the macrophage response (proinflammatory vs. immunomodulatory) against pathogens. Besides β-nicotinamide adenine dinucleotide 2'-phosphate, reduced (NADPH) oxidase, mitochondrial electron transport chain complexes release superoxide for direct killing of the pathogen. Mitochondria that are injured are removed by mitophagy, and this process can be critical for regulating macrophage activation. For example, impaired mitophagy can result in cytosolic leakage of mitochondrial DNA (mtDNA) that can lead to activation of cGAS–STING signaling pathway of macrophage proinflammatory response. In this review, we will discuss how metabolism, mtDNA, mitophagy, and cGAS–STING pathway shape the macrophage response to infectious agents.
Introduction
Macrophages (Mφ) are innate immune cells that reside in almost all of the tissues in the body. Two major lineages of Mφ include the blood-circulating monocytes originating from the myeloid progenitor cells in the bone marrow (BM) and those derived from the yolk sac (1). Mφ of both lineages are capable of responding to microbial invasion and other stimuli through production of proinflammatory molecules e.g. tumor necrosis factor (TNF)-α, interleukin (IL)-6, nitric oxide (NO), and reactive oxygen species (ROS), recruitment of immune cells, and antigen presentation to T cells for the initiation of adaptive immunity (2). Mφ may also play a role in resolution of inflammation and tissue injury by upregulating the anti-inflammatory mediators and scavenging receptors (e.g. mannose receptor), phagocytizing cellular debris, and secreting molecules [e.g., metalloproteinase (MMP)-2, MMP-9, tumor growth factor (TGF)-β] to induce collagen production and scar formation associated with tissue repair and wound healing (3, 4). In recent studies, mitochondrial health and metabolic status have been recognized as drivers of Mφ response (5). For example, a switch in energy production from mitochondrial oxidative metabolism towards glycolysis elicits Mφ proinflammatory polarization (6). Bacterial lipopolysaccharide (LPS) elicits a large and transient increase in nicotinamide adenine dinucleotide (NAD+) levels, which supports TNF-α production; and NAD+ deficiency had an inhibitory effect on TNF-α release (7). Depletion of cytoplasmic NAD+ induces an impairment in adhesion and phagocytosis of zymosan particles (8).
A compromise in mitochondrial health in the presence of exogenous or endogenous stimuli may signal proinflammatory Mφ response through multiple routes, including release of mitochondrial ROS (mtROS) and mtDNA that interact with multiple receptors [e.g. cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)] and transcription factors [e.g. nuclear factor kappa B (NF-κB)] (7). In this context, Mφ response may also be regulated by mitophagy involved in clearance of damaged and/or dysfunctional mitochondria (8). In this review, we will discuss how mitochondrial health vs mitochondrial dysfunction and compromised mitophagy shape the Mφ response. We will also discuss the signaling pathways (i.e., cGAS/STING) that link mitochondrial control of Mφ response in health and disease.
Diverse Functions of Macrophages
Macrophages exhibit remarkable flexibility in responding to pathogenic, environmental, and endogenous stimuli. Mφ utilize surface and cytosolic pattern recognition receptors (PRRs) to recognize pathogen associated molecular patterns (PAMPs) that are the molecules expressed by pathogens and the damage associated molecular patterns (DAMPs) which serve as immune activators when they are exposed under conditions of stress or injury. Major classes of PRR include C-type lectin receptors, NOD-like receptors, RIG-I-like receptors, and toll-like receptors (TLRs). PRR recognition of PAMPs and DAMPs initiates complex signaling cascade and interplay of cellular mediators and transcription factors that shape the Mφ defense against invading or intracellular pathogen or Mφ response for removal of cellular debris left after exposure to pathogenic and injurious stimuli. In-depth discussion of PRRs’ function can be found in several recent articles (e.g. 9, 10).
Proinflammatory Response
Lipopolysaccarides (LPSs), components of the outer membrane of gram-negative bacteria, are perhaps the most studied PAMPs that are recognized by TLR4 and shown to elicit proinflammatory response in Mφ. TLRs, through a series of phosphorylation steps, signal the recruitment and degradation of proteins and kinases including TNF receptor associated factor 6 (TRAF6), myeloid differentiation primary response (MYD)88, and TGF-β activated kinase (TAK) that result in the induction of NF-κB transcription factor for the expression of proinflammatory molecules (11). Along with the PRRs, TNF-α and type II interferon (IFN)-γ are the most studied cytokines shown to enhance the proinflammatory activation of the Mφ via c-Jun N-terminal kinase (JNK)/signal transducers and activators of transcription (STAT)-1 signaling of NF-κB and hypoxia inducible factor (HIF)-1α transcription factors (12, 13). The classical model of Mφ activation by LPS/IFN-γ triggers an extensive profile of inflammatory cytokines (e.g. TNF-α, IL-6, IL-1β) and chemokines (such as CCL2/MCP-1, CCL3, CCL4, CCL5, CCL11, and CCL13) and are referred as proinflammatory or M1 phenotype (14). A feedback control of M1 Mφ activation is provided by a suppressor of cytokine signaling (SOCS) inhibition of STAT-3. The proinflammatory Mφ are also expected to generate high levels of reactive oxygen and nitrogen species which contribute to direct killing of the pathogen.
In Mφ, NADPH oxidase is considered to be the primary source of superoxide (O2•−) that then is dismutated to peroxides, hydroxyl radical, and other forms of ROS (15). Recent studies have also addressed the role of mitochondrial respiration in contributing to ROS production in Mφ (16). Inducible nitric oxide synthase (iNOS) serves as the major source of nitric oxide (NO) utilizing oxygen and L-arginine in the process (17). The O2•− and NO radicals, together, produce peroxynitrite (ONOO) involved in microbicidal activity. Costimulatory molecules such as cluster of differentiation (CD)80, CD86, CD64, CD16, CD32, and iNOS are used as markers of M1 Mφ. Type I and type III interferons mediated antiviral responses that are central to host defense against viral infections are discussed in recent reviewes (18, 19).
Immunomodulatory Response
On the other end of the spectrum is the Mφ activation to M2 state that involves heterogenous functional profile depending upon the stimulating factors (20). For example, IL-4 produced by Mφ and T helper type 2 (Th2) cells and IL-13 produced by various T cell subsets and natural killer (NK) cells stimulate Mφ polarization towards immunomodulatory M2a state associated with anti-inflammatory role with production of IL-10, IL-1 receptor II (IL-1RII), and anti-helminth Th2 inflammation (21, 22). M2b regulatory Mφ are capable of possessing both protective and pathogenic roles and are activated in response to TLRs, IL-1R or immune complexes (23). The M2c Mφ respond to glucocorticoids, TGF-β, IL-10 etc., and are involved in immune suppression, matrix deposition, tissue repair and tissue remodeling (24). The general mechanism underlying the M2 polarization includes the engagement of IL-4R, IL-10R, or IL-13R that signal through Janus kinase (JAK) and tyrosine kinase (TYK) to mediate an increase in STAT6 activity (25). STAT6 transcriptional activation is also enhanced by peroxisome proliferator activated receptor γ (PPAR-γ) and PPAR-γ coactivator 1 (PGC-1) that support the expression of genes involved in fatty acid (FA) oxidation and oxidative metabolism and have inhibitory effects on inflammatory gene transcription (26, 27). IL-4 and IL-13 also enhance the expression of the mannose receptor (CD206), dectin-1, and resistin-like molecule (RELM)-α, which play an important role in the recognition of fungal infections and activation of Th2 immunity (27). IL-10 activates STAT1 more than STAT3 and inhibits inflammatory cytokine (e.g., TNF-α and IL-1β) production (28). Polarization of M2 Mφ towards M1 phenotype is prevented through SOCS-3 inhibition of STAT-3. Co-stimulatory molecules, including arginase 1 (supports cell proliferation), decoy receptor 3 (inhibits Fas ligand induced apoptosis), dectin 1 (a major β glucan receptor), CD206, and CD163 (scavenger receptor) are used as markers of M2 Mφ. We note that this classification is not sufficient to cover the wide range of Mφ activation profile noted in various in vivo models of infection and other diseases.
Phagocytosis
Macrophages are classical phagocytes that uptake and degrade pathogens as well as cellular debris by an actin dependent and clathrin-independent mechanism. Phagocytosis in Mφ is activated by recognition through the complement-, Fcγ-, or mannose-receptors [reviewed in (29)]. The fusion of phagosome with lysosome filled with hydrolytic enzymes forms a phagolysosome where the engulfed material is digested and then disposed by exocytosis or the immunodominant peptides are loaded on to MHC. MHCII molecules translocate to cell surface for presentation of the antigen to CD4+T cells (30). Macropinocytosis (non-specific uptake of soluble antigens) and receptor-mediated endocytosis of soluble antigens through clathrin-coated vesicles also deliver the antigenic peptides through endosome lysosome pathway for MHCII presentation (30). Some microbes that escape from phagolysosome into cell cytoplasm (e.g. Trypanosoma cruzi) and others that develop intracellularly (e.g. viruses) are degraded by proteasomes after which immunodominant peptides bind to MHCI molecules which are recognized by CD8+T cells (31). Thus, as a professional antigen-presenting cell (APC), Mφ bridge the innate and adaptive immune systems.
Besides traditional phagocytosis that is mostly reserved for uptake of pathogens, Mφ are also involved in the uptake and clearance of apoptotic bodies. For this, Mφ respond to “eat-me” signals including nucleotides, chemokines, and lipid phosphatidylserine on the apoptotic cells by upregulation of the mannose receptors (CD163, CD206), cytokines (TGF-β and IL-10), arachidonic metabolites (e.g., prostaglandin E2), and pro-resolving mediators that is then followed by anti-inflammatory and repair/healing responses (32). Further details on Mφ role in clearance of apoptotic cells can be found in a recent review (33).
Metabolic Switch and Functional Profile of Macrophages
Mitochondrial respiration and metabolism machinery, i.e., tricarboxylic acid (TCA) cycle, electron transport chain (ETC), oxidative phosphorylation (OXPHOS), and fatty acid and amino acid metabolism provide the energy house status to mitochondria. Interestingly, these same metabolic pathways, along with glycolysis and pentose phosphate pathway (PPP), influence the functional polarization of Mφ and are discussed in brief here.
Metabolic Switch to Glycolysis in Proinflammatory Macrophages
Newsholme et al. (34) have noted a direct correlation between the increase in the rate of glycolysis and phagocytosis upon macrophage activation by inflammatory stimuli. Since then, the advent of new reagents and mass spectrometry approaches has facilitated large scale metabolome studies. Researchers have utilized these new approaches to address how metabolic profile impacts Mφ activation and the mechanisms employed by Mφ to switch metabolic program in response to various stimuli. Now, we know that proinflammatory Mφ induced by LPS/IFN-γ have impaired activities of the TCA, ETC, and OXPHOS pathways and rely on increased glucose uptake and glycolysis for energy needs and production of ROS/NO and proinflammatory cytokines (35). LPS-activated Mφ also utilize the glucose metabolic intermediates for triglycerides and FA synthesis and engulf free fatty acids for triglyceride accumulation (36), which are vital for their phagocytic function (37). Glycolysis in LPS-stimulated and M1-like Mφ is supported by upregulation of glucose transporter 1 (GLUT1), hexokinase 2 (catalyzes rate limiting first step of glycolysis) (38), ubiquitous 6-phosphofructo-2-kinase (uPFK2, produces higher concentrations of fructose 2,6-bisphosphate substrate than other isoforms), and pyruvate kinase M2 (PKM2, catalyzes final step of glycolysis) (39). Mφ switch to glycolysis is mediated by HIF-1α. In normal conditions, nuclear prolyl hydroxylase 1 (PHD1) produces 2S,4R-4-hydroxyproline from α-ketoglutarate for post-translational hydroxylation of HIF-1α that is then targeted for proteasomal degradation (40). Under hypoxic conditions, PHD1 inhibition allows stabilization and activation of HIF-1α (40). Nuclear localization of PKM2 enhances the STAT3 phosphorylation and HIF-1α transcriptional activity thereby facilitating increase in proinflammatory cytokines expression (41). HIF-1α also stimulates the expression of GLUT1, monocarboxylate transporter 4 (MCT4), and uPFK2 and induces lactate dehydrogenase (utilizes pyruvate to make lactate) and pyruvate dehydrogenase kinase (inhibits pyruvate entry into TCA cycle) that together promote glycolysis in Mφ (discussed in 6).
The 13C metabolite labeling studies suggest that TCA cycle is disrupted at distinct points in M1 Mφ. Accumulation of succinate signals the stabilization of HIF-1α (42) and succinate-responsive succinate receptor 1 (SCNR1) and regulates ROS and IL-1β release in classically activated Mφ (43). Isocitrate dehydrogenase downregulation contributes to accumulation of citrate that is deemed important for the synthesis of the anti-bacterial itaconate compound (43). Further, excess citrate is transported from the mitochondria to cytosol where it is converted by citrate lyase to acetyl CoA and used for FA synthesis in proinflammatory Mφ (44). Other intermediates of TCA cycle, e.g. fumarate, succinate, and α-ketoglutarate are suggested to regulate the Mφ activation profile through influencing the epigenome (45).
Pentose phosphate pathway (PPP) branches off from glycolytic pathway with formation of 6-phosphate gluconate and NADPH from glucose-6-phosphate and serves an important role in nucleotide synthesis. Mφ utilize NADPH produced by PPP as electron carrier for ROS formation by NADPH oxidase (46) and as a co-substrate with L-arginine for the synthesis of L-citrulline and NO by inducible nitric oxide synthase (iNOS) (47). L-citrulline can also be involved in L-arginine biosynthesis to feed the cyclic and continuous NO generation in proinflammatory Mφ (48). With regard to mitochondria, a decline in bioavailability of NAD+ due to depletion of tryptophan (co-substrate for NAD+ biosynthesis) or decreased influx from malate-aspartate and the glycerol-3-phosphate shuttles can disturb the NAD+/NADH ratio. Alternatively, an accumulation of NADH in the mitochondria due to decreased OXPHOS requirement results in disturbances of the NAD+/NADH ratio. Such flux in NAD+/NADH can disturb mitochondrial membrane potential and ETC complexes and consequently causes increased leakage of electrons to O2 favoring O2•− production in Mφ (49–52). Besides ETC, α-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes are also recognized as site of mtROS production (53, 54).
Oxidative Metabolism in Immunomodulatory Macrophages
Immunoregulatory (M2 type) Mφ rely on TCA cycle and OXPHOS sourced from FA uptake and lipids/FA oxidation to meet the energy demand (55). M2 Mφ depend on adenosine monophosphate-activated protein kinase (AMPK) and peroxisome proliferator activating receptors (PPARs) mediated activation of STAT6 transcription complex to promote the expression of genes for OXPHOS and FA oxidation pathways (56). Treatment with chemical inhibitors of OXPHOS pathway or of ATP synthase downregulated the M2-specific expression of genes (e.g. Arg1, Mrc1), surface markers (CD206), and arginase 1 activity in IL-4-stimulated Mφ (35). Conversely, LPS + IFN-γ-stimulated M1 Mφ lacked the competence to restore mitochondrial respiration and M2-specific receptor expression after IL-4 treatment (35). Collectively, current literature suggests that M2-like Mφ have an intact TCA cycle, FA oxidation, and aerobic glycolysis, while M1-like Mφ tend to depend on breakdown intermediates of glycolysis, PPP, and TCA cycle.
Metabolic Regulation of Macrophages in Infection
Very few studies have addressed the metabolic regulation of Mφ polarization in experimental models of health and disease, though metabolic perturbations elicited in Mφ by various infectious agents have been reported. For example, Mycobacterium tuberculosis invasion of Mφ was accompanied by increase in expression of glucose transporters and glucose uptake (57). Further, M. tuberculosis augmented the aerobic glycolysis that was associated with delayed apoptotic response of Mφ and increased replication and survival of the bacteria in Mφ (57). In contrast, HIV dampened the glucose uptake, glycolysis, and PPP intermediates to inhibit proinflammatory Mφ activation (58). Likewise, Francisella tularensis suppressed the lactate and HIF-1α stabilization and aerobic glycolysis in Mφ to ensure early replication of the bacteria (59). Salmonella infection activated M2 Mφ polarization despite the PPAR-δ mediated increase in glucose availability and favored the bacterial replication (60, 61). Pathogenic protozoans survive in Mφ and use Mφ as a vehicle for dissemination. For example, Leishmania sps. and Toxoplasma gondii utilized arginine metabolism for the synthesis of polyamines for their growth and replication in Mφ (62, 63). Leishmania also enhanced the AMPK/Sirtuin 1 (SIRT1) activity that supports mitochondrial metabolism (64) and levels of M2-associated intracellular metabolites (65), while glucose consumption was decreased in infected Mφ (65). Trypanosoma cruzi infection enhanced the expression of peroxisome proliferation activated receptor α (PPAR-α) in Mφ (66), and PPAR isoforms have been implicated in the gene transcription roles in M2 Mφ by several research groups (67). The cruciality of the PPP for providing substrates for ROS and NO production to control T. cruzi in Mφ was also noted (66). Others have indicated that PPP production of NADPH is utilized by T. cruzi to activate its antioxidant enzymes (e.g. trypanothione reductase) as defense against ROS/NO produced in Mφ (68). Together, these studies indicate that infectious agents employ various strategies to hijack the Mφ metabolism machinery for their own survival and replication; and microbe-specific studies identifying the steps in metabolic pathway(s) and/or metabolites that can be targeted to enhance the pathogen clearance by Mφ are required.
Other Mitochondrial Pathways Inter-Linked With MACROPHAGE Response to Pathogens
Besides metabolic control, the mitochondria play several other key regulatory roles in shaping the Mφ response and reviewed in brief here.
Apoptosis
In conditions of stress, a feedback cycle of mitochondrial permeability transition (MPT), disturbance of electrochemical proton gradient across the respiratory chain complexes and mtROS production occurs. The mtROS and ROS-induced oxidants result in oxidation of glutathione and thiol (e.g. N-acetyl cysteine) pools that inhibit apoptosis (69) or through oxidation at mitochondrial membranes that generate MPT lead to cytochrome c (cyt c) release. Cytosolic cyt c interacts with apoptotic protease activating factor 1 (APAF-1) initiating recruitment and activation of caspase-9 and other effector caspases (caspase-3, -6, -7) leading to cell apoptosis (70, 71). Mitochondrial apoptosis-inducing factor and endonuclease G have also been identified as key signaling molecules of apoptosis (72) A wide range of pathogens, pathogen-shed vesicles, and bacterial toxins have been associated with mitochondrial disturbances, cyt c release and activation of apoptosis in Mφ. For example, Shigella flexneri invasion induced mitochondrial MPT and signaled cell death in Mφ (73). M. tuberculosis was shown to induce Bax translocation to the mitochondria, MPT, and cytosolic cyt c release in infected Mφ (73, 74). Bacillus anthracis lethal toxin and Staphylococcus aureus secreted pore-forming toxins signaled activation of NLRP1B (75, 76) and NLRP3 (77, 78) inflammasomes, respectively, which led to caspase-1 and IL-1β activation and Mφ pyroptosis (highly inflammatory form of programmed cell death), though mitochondrial involvement was not reported.
Mitochondrial Fusion and Fission
Mitochondrial dynamics (i.e., repetitive cycles of fusion and fission) and mitophagy maintain mitochondrial homeostasis (79). For fusion, transmembrane dynamin related GTPase proteins named mitofusins (MFN1/MFN2) form dimers across the interface and tether mitochondria together. Mitofusins utilize GTP hydrolysis and redox signaling to induce conformation changes and enforce mitochondrial outer membrane fusion. Conversely, ubiquitination targets mitofusins for degradation that involves PTEN-induced kinase (PINK)1, Parkin, E3 ligase Huwe1, and Bcl-2 family members. Another dynamin related GTPase protein, optic atrophy protein 1 (OPA1) interacts with cardiolipin localized in cristae and intermembrane space to coordinate fusion of inner mitochondrial membranes. Mitochondrial fission involves dynamin related protein 1 (DRP1) and other adapter proteins that form a ring across the outer mitochondrial membrane. DRP1 is regulated by a variety of post-translational modifications, and organization of DRP1 ring offers conformational activation of GTPase activity leading to spiral constriction and separation of damaged and healthy mitochondrial portions (80). Fission 1 protein, regulated by ubiquitination by mitochondrial ubiquitin ligase, is involved in DRP1 binding, and it facilitates fragmentation of damaged portion of the mitochondria. Several other proteins, e.g., mitochondrial fission factor (MFF), TNFR-associated protein 1 (TRAP1), and mitochondrial dynamics proteins (MID49, MId51) are also involved in the fission process, though their role is not fully explored (81).
Studies on the role of mitochondrial fission and fusion in pathogen control have yielded important results. An increase in mitochondrial fission and mtROS production that activated the NF-κB mediated expression of proinflammatory mediators was observed in LPS-stimulated microglial Mφ (82). Streptococcus pneumoniae infection triggered mitochondrial fission allowing energy switch and enhanced mtROS production in Mφ (83). Helicobacter pylori vacuolating toxin induced DRP1 activation, mitochondrial fragmentation, Bax translocation to mitochondria, and cyt c release, and it was suggested that H. pylori targets mitochondrial fragmentation and apoptosis to prevent proinflammatory Mφ response (84). Likewise, Chlamydia trachomatis maintained mitochondrial integrity and predominance of OXPHOS pathway through a miR-30c-5p-dependent inhibition of Drp1-mediated mitochondrial fission (85). Vibrio cholerae targeted mitochondrial Rho Miro GTPases to modulate mitochondrial dynamics and interfere with innate immunity (86). Overexpression of MFN2 increased the M. tuberculosis growth in Mφ (87). However, a recent study showed that LPS-induced MFN2 was required for the adaptation of mitochondrial respiration to stress conditions and increase in ROS production and phagocytosis activity in Mφ (88). Mφ treated with MFN2 inhibitor or knocked down in MFN2 encoding gene exhibited a significant decline in phagocytosis of apoptotic bodies, Aeromonas hydrophila and E. coli (88). Studies in mice with myeloid-specific MFN1 and MFN2 knockdown revealed that MFN2 (not MFN1) deficiency impaired the production of proinflammatory cytokines and nitric oxide. MFN2 deficiency was also associated with dysfunctional autophagy, apoptosis, and phagocytosis, and MFN2 depleted mice failed to control Listeria and M. tuberculosis infections (88). These observations support the notion that mitochondrial dynamics is closely linked to the phagocytic capacity and immune function of Mφ during infection.
Mitochondrial Biogenesis
Mitochondrial biogenesis refers to the process by which cells increase mitochondrial mass (89). Peroxisome proliferator-activated receptor gamma coactivator-1α (PGC1α) plays an important role in the activation of nuclear respiratory factors (NRF-1, NRF-2) and nuclear factor erythroid 2-related factor 2 (Nfe2l2) transcription factors that regulate the expression of nuclear DNA and mtDNA encoded genes for mitochondrial biogenesis (90, 91). Recent discoveries indicate that mitochondrial biogenesis is intricately engaged with inflammatory/immunomodulatory host response. For example, it is suggested that early-phase inflammatory mediator proteins interact with pathogen recognition receptors to activate NF-κB-, MAPK-, or protein kinase B/Akt-dependent pathways, resulting in increased expression and activity of cofactors and transcription factors involved in mitochondrial biogenesis [reviewed in (92)]. Nitric oxide and ROS generated by Mφ can stimulate PGC-1α/Nfe2l2 or redox-sensitive hemoxygenase systems, causing simultaneous induction of mitochondrial biogenesis and antioxidant gene expression and modulate inflammation (93, 94). Sirtuin 1 (SIRT1), a highly conserved member of the Sir2 histone deacetylases family, is also implicated in deacetylation of PGC1α at multiple lysine sites, consequently increasing PGC1α activity (95). Specifically, Staphylococcus aureus is shown to upregulate mitochondrial biogenesis through the upregulation of the PGC family (96, 97). The induction of mitochondrial biogenesis was dependent on TLR2 and TLR4, signifying that the innate immune function feeds into the regulation of mitochondrial health during bacterial infection (97). Plataki et al. (98) noted decreased ATP production, dysregulated mitochondrial gene expression, and decreased numbers of healthy mitochondria in aged adult Mφ and lungs in response to S. pneumoniae infection and showed that treatment with an anti-fibrotic drug improved the mitochondrial mass and health in aged Mφ and decreased the pulmonary edema in aged mouse lung during infection. Human cytomegalovirus also induced mitochondrial biogenesis accompanied with increased respiration, both of which were required for the viral replication (99). Summarizing, the complex network of pro- and anti-inflammatory pathways impact and, are impacted by, mitochondria. While some infectious agents exploit mitochondrial biogenesis to establish infection in the host, maintenance of mitochondrial biogenesis, health, and function, and cellular redox status is vital to host survival in unregulated acute inflammatory states such as sepsis.
Mitophagy
Mitophagy is a process used for the removal of fragmented mitochondria, and detailed mechanism of mitophagy is discussed in a recent review (79). Briefly, mitophagy is triggered by outer membrane receptor proteins (e.g., NIX/BNIP3L, BNIP3, and FUNDC) that have a classic motif to bind directly to microtubule associated light chain 3 (LC3) and initiate mitophagy (100). Mitophagy is also initiated by the PTEN-induced kinase 1 (PINK1)/Parkin. Loss of membrane potential in damaged mitochondria supports the accumulation of unprocessed PINK1 on the outer membrane surface where it recruits cytosolic Parkin to promote ubiquitin dependent mitophagy through interaction with LC3 protein (101).
In context to cell damage caused by invading and intracellular microbes, autophagy/mitophagy act as important defense systems to establish homeostasis in stressful cellular environment. Indeed, inhibition of mitophagy by 3-methyladenine resulted in Mφ polarization towards M1 phenotype (102), while rapamycin mediated induction of autophagy suppressed the mtROS and NLRP3 inflammasome activation and favored Mφ polarization towards M2 phenotype (102, 103). Further, PINK1 depletion enhanced the LPS/IFN-γ stimulated proinflammatory phenotype in microglial cells (104), and adoptive transfer of Pink1-deficient bone marrow promoted Mφ proinflammatory activation, which favored pathogen clearance and increased survival in a murine model of polymicrobial infection (8). However, PINK1 was required to trigger the RIG-I-mediated innate immune responses in Mφ infected with respiratory syncytial and herpes simplex viruses (105), and Parkin-deficiency increased the susceptibility of mice to intracellular pathogenic bacteria (e.g., M. tuberculosis, S. typhimurium, L. monocytogenes, and Pseudomonas aeruginosa (106, 107). Likewise, autophagy activation by isoniazid and bedaquiline treatment impaired the mycobacterial phagosome escape in Mφ, suggesting that drugs favoring autophagy would enhance bacterial clearance (108). These studies highlight that mitophagy has important and diverse roles in modulating the innate immunity against pathogens.
DNA Sensing by cGAS–Sting in Macrophage Activation
The cytosolic presence of mtDNA in Mφ can occur due to uptake of fragmented/damaged mitochondria released in the peripheral system by other cells or due to leakage of mtDNA from their own mitochondria. The mtDNA contains a significant number of unmethylated CpG DNA repeats, similar to those present in prokaryotic bacterial genome (109) and is recognized as a cellular DAMP. The role of mtDNA as a key inducer of inflammatory cytokines (IL-1β and IL-18) in Mφ through recognition by TLR9 and activation of NLRP3/ASC inflammasome has been recognized in previous studies (110, 111). The cytoplasmic mtDNA co-localizes with NLRP3 to induce IL-1β secretion and oxidized mtDNA is a potent inducer of IL-1β production in Mφ (112). Further, NLRP3 activators trigger mtROS production, oxidized mtDNA release into cytosol and also mtDNA synthesis (without increase in mitochondrial mass) to fuel the proinflammatory activation in Mφ (113, 114). Detailed information on mtDNA signaling of inflammasomes can be found in recent reviews (115–117).
The pivotal role of double-stranded DNA sensor cGAS and STING in shaping the immune-surveillance by Mφ has been recognized recently (118). Briefly, STING was identified in 2008 (119) and cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) was recognized as a novel secondary messenger serving as ligand of STING in 2013 (120). Subsequently, cGAS was noted to have cytosolic DNA-sensing ability, and the cGAS–STING pathway was identified to be indispensable for anti-viral host immunity (121). Later on, mtDNA and oxidized DNA were identified as key molecules to be recognized by cGAS–STING for the initiation of anti-viral type I interferon immunity (122). These authors showed that mtDNA stress elicited by a mitochondrial transcription factor A deficiency promoted mtDNA escape into cytosol where it engaged cGAS and signaled STING–IRF3-dependent increase in the expression of interferon stimulated genes (ISGs) in herpes viruses infection model (122). The findings that inhibition of DNA repair enzyme 8-oxoguanine DNA glycosylase 1, which removes 8-oxo-7,8-dihydroguanine lesions caused by ROS, enhanced the mtDNA-cGAS–STING–IRF3–IFN-β axis in favor of Mφ control of P. aeruginosa (123) showed that oxidized DNA is a more potent activator of cGAS–STING pathway. Indeed, impaired activity of DNA damage repair response mediators, such as ataxia telangiectasia mutated (ATM)-RAD3, poly ADP-ribose polymerase (PARP), and breast cancer1/2 (BRCA1/2) is associated with persisting double-stranded DNA breaks, accumulation of cytosolic DNA and activation of cGAS–STING pathway (124–126). The bone marrow derived dendritic cells and Mφ from cGAS−/−, STING−/−, or IRF-3−/− mice were deficient in anti-adenoviral responses (127, 128); however, cGAS−/− and STING−/− mice were not defective in the induction of adaptive immunity and achieved adenoviral clearance at a similar rate as was noted in WT mice (128).
Mechanistically, it was shown that activated STING binds to and be phosphorylated by TANK binding kinase 1 (TBK1) dimer or IκB kinase (IKK) (129, 130) and it was suggested that STING–TBK1/IKK signalosome produces a scaffold to phosphorylate IRF3 (activate-form) or inhibitor of NF-κBα (targeted for degradation) and consequently, signal IRF3-dependent type 1 ISGs and NF-κB activation, respectively. TBK1 is also suggested to control STING stimulation. The p62/SQSTM1, which is phosphorylated by TBK1, directs ubiquitinated STING to autophagosome for degradation (131). Others indicated that caspase-9 and caspase-3 can cleave cGAS and IRF3 to restrain deleterious inflammation.
The cGAS–STING has also been reported to interact with the autophagy machinery. The STING–TBK1 activation and ISG expression induced ER stress and mechanistic target of rapamycin complex 1 (mTORC1) dysfunction (132, 133). Both ER stress and mTORC1 disturbances can signal Unc-51-like autophagy activating kinase (ULK1) and Beclin-1-class III phosphatidylinositol 3-kinase (PI3KC3) complexes, which together promote initiation of the classical autophagy (132, 133). cGAS was also indicated to directly interact with beclin-1-PI3KC3 complex to trigger autophagy (134). Further, cGAS–STING-mediated inflammation was mitigated by PINK1 and Parkin, which promote the clearance of damaged mitochondria (135). Some studies have also implicated the crosstalk between cGAS–STING and autophagy in pathogen clearance. For example, STING recognition of extracellular mycobacterial DNA enhanced the bacilli delivery to autophagosomes, and mice with monocytes incapable of delivering bacilli to the autophagy pathway were extremely susceptible to infection (136). Direct interaction between cGAS and beclin-1 not only halted the innate immune response against herpes simplex virus-1 infection but also enhanced the autophagy-mediated degradation of cytosolic pathogen DNA to prevent excessive cGAS activation and persistent immune stimulation (134). These findings suggest that autophagy/mitophagy provide a negative feedback control on over-activation of the cGAS–STING-mediated inflammation.
Non-Coding RNA Regulation of Mitochondrial Health and Its Potential to Influence Innate Immunity
A significant portion of the eukaryotes’ genome encodes for non-coding RNAs (ncRNAs) of different sizes. The ncRNAs regulate diverse biological processes, and their significance in regulation of mitochondrial metabolic function has been recognized recently. In this section, we briefly discuss the influence of ncRNAs in shaping the mitochondrial health and interpolate its potential effects in shaping the host innate immunity.
Short, non-coding micro(mi)RNAs (~22 bp) regulate the gene expression by binding to the promoters, 5′ and 3′ untranslated regions (UTRs), or open reading frame (ORF) of the targeted mRNAs. For example, miR-23a/23b miRNAs participated in the regulation of mitochondrial TCA cycle via activation of glutaminase enzyme (137), and miR-30 family members inhibited mitochondrial fission and apoptosis through suppressing the p53 and Drp1 expression (138). These miRNAs, if present in Mφ, would potentially favor M2 phenotype. Conversely, several miRNAs suppress mitochondrial homeostasis and have a potential to favor M1 Mφ phenotype. Examples include miR-696 that inhibited FA oxidation and mitochondrial biogenesis by PGC-1α (139), miR-210 (upregulated in hypoxic conditions) that blocked mitochondrial respiration by inhibiting Isc gene homologs encoding for the iron sulfur clusters (140), and miR-195 that directly inhibits SIRT3 implicated in regulating mitochondrial metabolism (141). The miR-762 was recently shown to translocate to the mitochondria and inhibit translation of ND2 subunit of mitochondrial complex I, which enhanced mtROS generation (142).
Non-coding circular RNAs (circRNAs) form a covalent bond between their 5′ and 3′ ends and exhibit significant resistance to exonucleases. A mitochondrial fission and apoptosis-related circRNA (MFACR) was recently shown to enhance mitochondrial fission and apoptosis in cardiomyocytes, and MFACR knockdown attenuated mitochondrial fission and myocardial infarction in mice (143). Steatohepatitis-associated circRNA ATP5B Regulator (SCAR) is located in the mitochondria, where it binds to ATP5B and suppresses mtROS generation (144). Authors also showed that mitochondria-specific delivery of circRNA SCAR alleviated meta-inflammation in vivo (144). Mitochondrial genome-derived mc-COX2 circRNA was present in plasma of chronic lymphocytic leukemia (CLL); a decline in mc-COX2 affected mitochondrial functions and induced cell apoptosis and its upregulation was positively associated with worsening survival of CLL patients (145). How mitochondria targeted circRNAs influence inflammatory vs. immunomodulatory role of Mφ or other innate immune cells is not studied.
Long non-coding RNAs (lncRNAs; >200 nucleotides) bear many signatures of mRNAs, e.g., 5′ capping and polyadenylation and can impact gene expression by interacting with DNA, RNA, or proteins (146). LncRNAs play a role in mitochondrial homeostasis by directly influencing the expression and/or stability of the mRNAs encoding for mitochondrial proteins or by indirectly affecting the miRNAs that may govern the half-life of mRNAs responsible for mitochondrial health. A few lncRNAs encoded by mtDNA include lncND5, lncND6, and lncCytb (147), though their role in mitochondrial function is not known. Recently, lncRNA Cerox1 (cytoplasmic endogenous regulator of oxidative phosphorylation 1) was identified to enhance the mitochondrial complex I activity by blocking regulatory effects of miR-488-3p on mRNAs for complex I subunits (148). Tug1 (taurine-upregulated gene 1) lncRNA regulates PGC-1α activity, and its overexpression enhanced the mitochondrial bioenergetics in the podocyte of diabetic nephropathy (149). Several lncRNAs have been identified to regulate apoptosis through their influence on mitochondrial health. For example, inhibition of AK055347 lncRNA was detrimental to cells’ viability that was accompanied by downregulation of ETC, cyt P450, and ATP synthase (150). Cardiac apoptosis-related lncRNA (CARL) blocked mitochondrial fission and apoptosis by impairing miR-539-dependent PHB2 downregulation (151), while FAL1 lncRNA enhanced DRP1-mediated mitochondrial fission and apoptosis (152). GAS5 and SAMMSON lncRNAs are also shown to regulate apoptosis via diverse mechanisms.
Overall, it is becoming increasingly clear that ncRNAs, originated either from nuclear or mitochondrial genome, are involved in regulating the mitochondrial homeostasis and will have a role in shaping the innate immunity.
Summary
In this review, we have summarized the current literature on various roles of mitochondria in influencing the Mφ response. It is well recognized that the mitochondria can satisfy cell energy requirements by maintaining their dynamicity, and alterations in mitochondrial structure and dynamics can modulate Mφ immune response. The various mechanisms applied by pathogens to perturb and reprogram Mφ metabolic health in favor of their survival in the host are also appreciated in the current literature. We envision that novel therapeutic strategies targeting mitochondrial dynamics will be useful in controlling the pathogenic effects of the overly active immune system while achieving the beneficial effects against the intracellular pathogens.
Author Contributions
SC wrote first draft, IC wrote the section on ncRNAs, and SC and NG contributed to editing and writing of the final version. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by a grant from the National Institute of Allergy and Infectious Diseases (R01AI136031) of the National Institutes of Health to NG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Hume DA, Irvine KM, Pridans C. The Mononuclear Phagocyte System: The relationship between monocytes and macrophages. Trends Immunol (2019) 40:98–112. doi: 10.1016/j.it.2018.11.007
2. Haniffa M, Bigley V, Collin M. Human mononuclear phagocyte system reunited. Semin Cell Dev Biol (2015) 41:59–69. doi: 10.1016/j.semcdb.2015.05.004
3. Muraille E, Leo O, Moser M. TH1/TH2 paradigm extended: macrophage polarization as an unappreciated pathogen-driven escape mechanism? Front Immunol (2014) 5:603. doi: 10.3389/fimmu.2014.00603
4. Minutti CM, Knipper JA, Allen JE, Zaiss DM. Tissue-specific contribution of macrophages to wound healing. Semin Cell Dev Biol (2017) 61:3–11. doi: 10.1016/j.semcdb.2016.08.006
5. Tiku V, Tan MW, Dikic I. Mitochondrial functions in infection and immunity. Trends Cell Biol (2020) 30(4):263–75. doi: 10.1016/j.tcb.2020.01.006
6. Koo SJ, Garg NJ. Metabolic programming of macrophage functions and pathogens control. Redox Biol (2019) 24:101198. doi: 10.1016/j.redox.2019.101198
7. Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol (2018) 9:1487. doi: 10.3389/fphys.2018.01487
8. Patoli D, Mignotte F, Deckert V, Dusuel A, Dumont A, Rieu A, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. J Clin Invest (2020) 130(11):5858–74. doi: 10.1172/JCI130996
9. Olive C:. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Rev Vaccines (2012) 11:237–56. doi: 10.1586/erv.11.189
10. Mukhopadhyay S, Pluddemann A, Gordon S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Adv Exp Med Biol (2009) 653:1–14. doi: 10.1007/978-1-4419-0901-5_1
11. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4:499–511. doi: 10.1038/nri1391
12. Su X, Yu Y, Zhong Y, Giannopoulou EG, Hu X, Liu H, et al. Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation. Nat Immunol (2015) 16:838–49. doi: 10.1038/ni.3205
13. Green DS, Young HA, Valencia JC. Current prospects of type II interferon gamma signaling and autoimmunity. J Biol Chem (2017) 292:13925–33. doi: 10.1074/jbc.R116.774745
14. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 6:13. doi: 10.12703/P6-13
15. Panday A, Sahoo MK, Osorio D, Batra S. NADPH oxidases: an overview from structure to innate immunity-associated pathologies. Cell Mol Immunol (2015) 12:5–23. doi: 10.1038/cmi.2014.89
16. Lopez M, Tanowitz HB, Garg NJ. Pathogenesis of chronic Chagas Disease: macrophages, Mitochondria, and oxidative stress. Curr Clin Microbiol Rep (2018) 5:45–54. doi: 10.1007/s40588-018-0081-2
17. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res (1999) 43:521–31. doi: 10.1016/S0008-6363(99)00115-7
18. Mesev EV, LeDesma RA, Ploss A. Decoding type I and III interferon signalling during viral infection. Nat Microbiol (2019) 4:914–24. doi: 10.1038/s41564-019-0421-x
19. Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol (2020) 20:363–74. doi: 10.1038/s41577-020-0311-8
20. Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol (2018) 233(9):6425–40. doi: 10.1002/jcp.26429
21. Hoshino T, Winkler-Pickett RT, Mason AT, Ortaldo JR, Young HA. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol (1999) 162:51–9.
22. Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol (2013) 31:317–43. doi: 10.1146/annurev-immunol-032712-095906
23. Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol (2019) 106:345–58. doi: 10.1002/JLB.3RU1018-378RR
24. Anders CB, Lawton TMW, Ammons MCB. Metabolic immunomodulation of macrophage functional plasticity in nonhealing wounds. Curr Opin Infect Dis (2019) 32:204–9. doi: 10.1097/QCO.0000000000000550
25. Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol (2000) 105:1063–70. doi: 10.1067/mai.2000.107604
26. Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab (2012) 23:351–63. doi: 10.1016/j.tem.2012.05.001
27. Roszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm (2015) 2015:816460. doi: 10.1155/2015/816460
28. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol (2008) 180:5771–7. doi: 10.4049/jimmunol.180.9.5771
29. Richards DM, Endres RG. The mechanism of phagocytosis: two stages of engulfment. Biophys J (2014) 107:1542–53. doi: 10.1016/j.bpj.2014.07.070
30. Mantegazza AR, Magalhaes JG, Amigorena S, Marks MS. Presentation of phagocytosed antigens by MHC class I and II. Traffic (2013) 14:135–52. doi: 10.1111/tra.12026
31. Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol (2017) 17:349–62. doi: 10.1038/nri.2017.28
32. Arandjelovic S, Ravichandran KS. Phagocytosis of apoptotic cells in homeostasis. Nat Immunol (2015) 16:907–17. doi: 10.1038/ni.3253
33. Gordon S, Pluddemann A. Macrophage clearance of apoptotic cells: a critical assessment. Front Immunol (2018) 9:127. doi: 10.3389/fimmu.2018.00127
34. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J (1987) 242:631–6. doi: 10.1042/bj2420631
35. Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, van den Berg SM, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep (2016) 17:684–96. doi: 10.1016/j.celrep.2016.09.008
36. Feingold KR, Shigenaga JK, Kazemi MR, McDonald CM, Patzek SM, Cross AS, et al. Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol (2012) 92:829–39. doi: 10.1189/jlb.1111537
37. Ecker J, Liebisch G, Englmaier M, Grandl M, Robenek H, Schmitz G. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci USA (2010) 107:7817–22. doi: 10.1073/pnas.0912059107
38. Freemerman AJ, Johnson AR, Sacks GN, Milner JJ, Kirk EL, Troester MA, et al. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype. J Biol Chem (2014) 289:7884–96. doi: 10.1074/jbc.M113.522037
39. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol (2010) 185:605–14. doi: 10.4049/jimmunol.0901698
40. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem (2007) 282:4524–32. doi: 10.1074/jbc.M610415200
41. Demaria M, Poli V. PKM2, STAT3 and HIF-1alpha: The Warburg’s vicious circle. JAKSTAT (2012) 1:194–6. doi: 10.4161/jkst.20662
42. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature (2013) 496:238–42. doi: 10.1038/nature11986
43. Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell (2016) 167:457–70.e13. doi: 10.1016/j.cell.2016.08.064
44. Infantino V, Iacobazzi V, Palmieri F, Menga A. ATP-citrate lyase is essential for macrophage inflammatory response. Biochem Biophys Res Commun (2013) 440:105–11. doi: 10.1016/j.bbrc.2013.09.037
45. Ryan DG, Murphy MP, Frezza C, Prag HA, Chouchani ET, O’Neill LA, et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab (2019) 1:16–33. doi: 10.1038/s42255-018-0014-7
46. Ham M, Lee JW, Choi AH, Jang H, Choi G, Park J, et al. Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress. Mol Cell Biol (2013) 33:2425–35. doi: 10.1128/MCB.01260-12
47. Stuehr DJ. Enzymes of the L-arginine to nitric oxide pathway. J Nutr (2004) 134:2748S–51S. doi: 10.1093/jn/134.10.2748S
48. Wu GY, Brosnan JT. Macrophages can convert citrulline into arginine. Biochem J (1992) 281(Pt 1):45–8. doi: 10.1042/bj2810045
49. Jastroch M, Divakaruni AS, Mookerjee S, Treberg JR, Brand MD. Mitochondrial proton and electron leaks. Essays Biochem (2010) 47:53–67. doi: 10.1042/bse0470053
50. Al-Shabany AJ, Moody AJ, Foey AD, Billington RA. Intracellular NAD+ levels are associated with LPS-induced TNF-alpha release in pro-inflammatory macrophages. Biosci Rep (2016) 36:e00301. doi: 10.1042/BSR20150247
51. Petin K, Weiss R, Muller G, Garten A, Grahnert A, Sack U, et al. NAD metabolites interfere with proliferation and functional properties of THP-1 cells. Innate Immun (2019) 25:280–93. doi: 10.1177/1753425919844587
52. Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat Immunol (2019) 20:50–63. doi: 10.1038/s41590-018-0255-3
53. Starkov AA. An update on the role of mitochondrial alpha-ketoglutarate dehydrogenase in oxidative stress. Mol Cell Neurosci (2013) 55:13–6. doi: 10.1016/j.mcn.2012.07.005
54. Mailloux RJ. An update on mitochondrial reactive oxygen species production. Antioxidants (Basel) (2020) 9(6):472. doi: 10.3390/antiox9060472
55. Huang SC, Everts B, Ivanova Y, O’Sullivan D, Nascimento M, Smith AM, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol (2014) 15:846–55. doi: 10.1038/ni.2956
56. Al-Khami AA, Rodriguez PC, Ochoa AC. Energy metabolic pathways control the fate and function of myeloid immune cells. J Leukoc Biol (2017) 102:369–80. doi: 10.1189/jlb.1VMR1216-535R
57. Mehrotra P, Jamwal SV, Saquib N, Sinha N, Siddiqui Z, Manivel V, et al. Pathogenicity of Mycobacterium tuberculosis is expressed by regulating metabolic thresholds of the host macrophage. PLoS Pathog (2014) 10:e1004265. doi: 10.1371/journal.ppat.1004265
58. Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol (2010) 87:589–98. doi: 10.1189/jlb.0809580
59. Wyatt EV, Diaz K, Griffin AJ, Rasmussen JA, Crane DD, Jones BD, et al. Metabolic reprogramming of host cells by virulent Francisella tularensis for optimal replication and modulation of inflammation. J Immunol (2016) 196:4227–36. doi: 10.4049/jimmunol.1502456
60. Bowden SD, Rowley G, Hinton JC, Thompson A. Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar typhimurium. Infect Immun (2009) 77:3117–26. doi: 10.1128/IAI.00093-09
61. Eisele NA, Ruby T, Jacobson A, Manzanillo PS, Cox JS, Lam L, et al. Salmonella require the fatty acid regulator PPARδ for the establishment of a metabolic environment essential for long-term persistence. Cell Host Microbe (2013) 14:171–82. doi: 10.1016/j.chom.2013.07.010
62. Seabra SH, DaMatta RA, de Mello FG, de Souza W. Endogenous polyamine levels in macrophages is sufficient to support growth of Toxoplasma gondii. J Parasitol (2004) 90:455–60. doi: 10.1645/GE-179R
63. McConville MJ. Metabolic Crosstalk between Leishmania and the macrophage host. Trends Parasitol (2016) 32:666–8. doi: 10.1016/j.pt.2016.05.005
64. Moreira D, Rodrigues V, Abengozar M, Rivas L, Rial E, Laforge M, et al. Leishmania infantum modulates host macrophage mitochondrial metabolism by hijacking the SIRT1-AMPK axis. PLoS Pathog (2015) 11:e1004684. doi: 10.1371/journal.ppat.1004684
65. Lamour SD, Choi BS, Keun HC, Müller I, Saric J. Metabolic characterization of Leishmania major infection in activated and nonactivated macrophages. J Proteome Res (2012) 11:4211–22. doi: 10.1021/pr3003358
66. Koo SJ, Szczesny B, Wan X, Putluri N, Garg NJ. Pentose phosphate shunt modulates reactive oxygen species and nitric oxide production controlling Trypanosoma cruzi in macrophages. Front Immunol (2018) 9:202. doi: 10.3389/fimmu.2018.00202
67. Chawla A. Control of macrophage activation and function by PPARs. Circ Res (2010) 106:1559–69. doi: 10.1161/CIRCRESAHA.110.216523
68. Igoillo-Esteve M, Maugeri D, Stern AL, Beluardi P, Cazzulo JJ. The pentose phosphate pathway in Trypanosoma cruzi: a potential target for the chemotherapy of Chagas disease. Acad Bras Cienc (2007) 79:649–63. doi: 10.1590/S0001-37652007000400007
69. Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta (2016) 1863:2977–92. doi: 10.1016/j.bbamcr.2016.09.012
70. Bao Q, Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ (2007) 14:56–65. doi: 10.1038/sj.cdd.4402028
71. Dorstyn L, Akey CW, Kumar S. New insights into apoptosome structure and function. Cell Death Differ (2018) 25:1194–208. doi: 10.1038/s41418-017-0025-z
72. Hu WL, Dong HY, Li Y, Ojcius DM, Li SJ, Yan J. Bid-Induced Release of AIF/EndoG from mitochondria causes apoptosis of macrophages during infection with Leptospira interrogans. Front Cell Infect Microbiol (2017) 7:471. doi: 10.3389/fcimb.2017.00471
73. Koterski JF, Nahvi M, Venkatesan MM, Haimovich B. Virulent Shigella flexneri causes damage to mitochondria and triggers necrosis in infected human monocyte-derived macrophages. Infect Immun (2005) 73:504–13. doi: 10.1128/IAI.73.1.504-513.2005
74. Chen M, Gan H, Remold HG. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol (2006) 176:3707–16. doi: 10.4049/jimmunol.176.6.3707
75. Van Opdenbosch N, Gurung P, Vande Walle L, Fossoul A, Kanneganti TD, Lamkanfi M. Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. Nat Commun (2014) 5:3209. doi: 10.1038/ncomms4209
76. Levinsohn JL, Newman ZL, Hellmich KA, Fattah R, Getz MA, Liu S, et al. Anthrax lethal factor cleavage of Nlrp1 is required for activation of the inflammasome. PLoS Pathog (2012) 8:e1002638. doi: 10.1371/journal.ppat.1002638
77. Melehani JH, James DB, DuMont AL, Torres VJ, Duncan JA. Staphylococcus aureus Leukocidin a/b (lukab) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular. PLoS Pathog (2015) 11:e1004970. doi: 10.1371/journal.ppat.1004970
78. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-Tekippe E, et al. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One (2009) 4:e7446. doi: 10.1371/journal.pone.0007446
79. Pickles S, Vigie P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol (2018) 28:R170–R85. doi: 10.1016/j.cub.2018.01.004
80. Adaniya SM, OU J, Cypress MW, Kusakari Y, Jhun BS. Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology. Am J Physiol Cell Physiol (2019) 316:C583–604. doi: 10.1152/ajpcell.00523.2018
81. Cherok E, Xu S, Li S, Das S, Meltzer WA, Zalzman M, et al. Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics. Mol Biol Cell (2017) 28:396–410. doi: 10.1091/mbc.e16-04-0208
82. Park J, Choi H, Min JS, Park SJ, Kim JH, Park HJ, et al. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J Neurochem (2013) 127:221–32. doi: 10.1111/jnc.12361
83. Mohasin M, Balbirnie-Cumming K, Fisk E, Prestwich EC, Russell CD, Marshall J, et al. Macrophages utilize mitochondrial fission to enhance mROS production during responses to Streptococcus pneumoniae. bioRxiv (2019) 722603. doi: 10.1101/722603
84. Jain P, Luo ZQ, Blanke SR. Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc Natl Acad Sci USA (2011) 108:16032–7. doi: 10.1073/pnas.1105175108
85. Chowdhury SR, Reimer A, Sharan M, Kozjak-Pavlovic V, Eulalio A, Prusty BK, et al. Chlamydia preserves the mitochondrial network necessary for replication via microRNA-dependent inhibition of fission. J Cell Biol (2017) 216:1071–89. doi: 10.1083/jcb.201608063
86. Suzuki M, Danilchanka O, Mekalanos JJ. Vibrio cholerae T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe (2014) 16:581–91. doi: 10.1016/j.chom.2014.09.015
87. Lee J, Choi JA, Cho SN, Son SH, Song CH. Mitofusin 2-deficiency suppresses Mycobacterium tuberculosis survival in macrophages. Cells (2019) 8(11):1355. doi: 10.3390/cells8111355
88. Tur J, Pereira-Lopes S, Vico T, Marin EA, Munoz JP, Hernandez-Alvarez M, et al. Mitofusin 2 in macrophages links mitochondrial ROS production, cytokine release, phagocytosis, autophagy, and bactericidal activity. Cell Rep (2020) 32:108079. doi: 10.1016/j.celrep.2020.108079
89. Ohira Y, Cartier LJ, Chen M, Holloszy JO. Induction of an increase in mitochondrial matrix enzymes in muscle of iron-deficient rats. Am J Physiol (1987) 253:C639–44. doi: 10.1152/ajpcell.1987.253.5.C639
90. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab (2006) 4:13–24. doi: 10.1016/j.cmet.2006.05.011
91. Wan X, Wen JJ, Koo SJ, Liang LY, Garg NJ. SIRT1-PGC1alpha-NFkappaB pathway of oxidative and inflammatory stress during Trypanosoma cruzi infection: Benefits of SIRT1-targeted therapy in improving heart function in Chagas disease. PLoS Pathog (2016) 12:e1005954. doi: 10.1371/journal.ppat.1005954
92. Cherry AD, Piantadosi CA. Regulation of mitochondrial biogenesis and its intersection with inflammatory responses. Antioxid Redox Signal (2015) 22:965–76. doi: 10.1089/ars.2014.6200
93. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (2003) 299:896–9. doi: 10.1126/science.1079368
94. MacGarvey NC, Suliman HB, Bartz RR, Fu P, Withers CM, Welty-Wolf KE, et al. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit Care Med (2012) 185:851–61. doi: 10.1164/rccm.201106-1152OC
95. Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem (2010) 285:21590–9. doi: 10.1074/jbc.M109.070169
96. Haden DW, Suliman HB, Carraway MS, Welty-Wolf KE, Ali AS, Shitara H, et al. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med (2007) 176:768–77. doi: 10.1164/rccm.200701-161OC
97. Sweeney TE, Suliman HB, Hollingsworth JW, Piantadosi CA. Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS One (2010) 5:e11606. doi: 10.1371/journal.pone.0011606
98. Plataki M, Cho SJ, Harris RM, Huang HR, Yun HS, Schiffer KT, et al. Mitochondrial dysfunction in aged macrophages and lung during primary Streptococcus pneumoniae infection is improved with pirfenidone. Sci Rep (2019) 9:971. doi: 10.1038/s41598-018-37438-1
99. Kaarbo M, Ager-Wick E, Osenbroch PO, Kilander A, Skinnes R, Muller F, et al. Human cytomegalovirus infection increases mitochondrial biogenesis. Mitochondrion (2011) 11:935–45. doi: 10.1016/j.mito.2011.08.008
100. Wu X, Wu FH, Wu Q, Zhang S, Chen S, Sima M. Phylogenetic and molecular evolutionary analysis of mitophagy receptors under hypoxic conditions. Front Physiol (2017) 8:539. doi: 10.3389/fphys.2017.00539
101. Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci (2012) 125:795–9. doi: 10.1242/jcs.093849
102. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature (2011) 469:221–5. doi: 10.1038/nature09663
103. Ko JH, Yoon SO, Lee HJ, Oh JY. Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NFkappaB pathways in autophagy- and p62-dependent manners. Oncotarget (2017) 8:40817–31. doi: 10.18632/oncotarget.17256
104. Sun L, Shen R, Agnihotri SK, Chen Y, Huang Z, Bueler H. Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death. Sci Rep (2018) 8:383. doi: 10.1038/s41598-017-18786-w
105. Zhou J, Yang R, Zhang Z, Liu Q, Zhang Y, Wang Q, et al. Mitochondrial protein PINK1 Positively regulates rlr signaling. Front Immunol (2019) 10:1069. doi: 10.3389/fimmu.2019.01069
106. Manzanillo PS, Ayres JS, Watson RO, Collins AC, Souza G, Rae CS, et al. The ubiquitin ligase Parkin mediates resistance to intracellular pathogens. Nature (2013) 501:512–6. doi: 10.1038/nature12566
107. Kirienko NV, Ausubel FM, Ruvkun G. Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proc Natl Acad Sci USA (2015) 112:1821–6. doi: 10.1073/pnas.1424954112
108. Genestet C, Bernard-Barret F, Hodille E, Ginevra C, Ader F, Goutelle S, et al. Lyon TBsg: Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages. Tuberculosis (Edinb) (2018) 111:67–70. doi: 10.1016/j.tube.2018.05.014
109. Sharma N, Pasala MS, Prakash A. Mitochondrial DNA: Epigenetics and environment. Environ Mol Mutagen (2019) 60:668–82. doi: 10.1002/em.22319
110. Ward GA, McGraw K, McLemore AF, Lam NB, Hou H-A, Meyer BS, et al. Oxidized mitochondrial DNA engages TLR9 to activate the NLRP3 inflammasome in myelodysplastic syndromes. Blood (2019) 134:774. doi: 10.1182/blood-2019-122358
111. Wu G, Zhu Q, Zeng J, Gu X, Miao Y, Xu W, et al. Extracellular mitochondrial DNA promote NLRP3 inflammasome activation and induce acute lung injury through TLR9 and NF-kappaB. J Thorac Dis (2019) 11:4816–28. doi: 10.21037/jtd.2019.10.26
112. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 36:401–14. doi: 10.1016/j.immuni.2012.01.009
113. Coll RC, Holley CL, Schroder K. Mitochondrial DNA synthesis fuels NLRP3 activation. Cell Res (2018) 28:1046–7. doi: 10.1038/s41422-018-0093-8
114. Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature (2018) 560:198–203. doi: 10.1038/s41586-018-0372-z
115. He Y, Hara H, Nunez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci (2016) 41:1012–21. doi: 10.1016/j.tibs.2016.09.002
116. Piantadosi CA. Mitochondrial DNA, oxidants, and innate immunity. Free Radic Biol Med (2020) 152:455–61. doi: 10.1016/j.freeradbiomed.2020.01.013
117. Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep (2020) 21:e49799. doi: 10.15252/embr.201949799
118. Wan D, Jiang W, Hao J. Research advances in how the cGAS-STING pathway controls the cellular inflammatory response. Front Immunol (2020) 11:615. doi: 10.3389/fimmu.2020.00615
119. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 455:674–8. doi: 10.1038/nature07317
120. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science (2013) 339:786–91. doi: 10.1126/science.1232458
121. Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science (2013) 341:1390–4. doi: 10.1126/science.1244040
122. West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature (2015) 520:553–7. doi: 10.1038/nature14156
123. Qin S, Lin P, Wu Q, Pu Q, Zhou C, Wang B, et al. Small-molecule inhibitor of 8-oxoguanine DNA glycosylase 1 regulates inflammatory responses during Pseudomonas aeruginosa infection. J Immunol (2020) 205:2231–42. doi: 10.4049/jimmunol.1901533
124. Heijink AM, Talens F, Jae LT, van Gijn SE, Fehrmann RSN, Brummelkamp TR, et al. BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity. Nat Commun (2019) 10:100. doi: 10.1038/s41467-018-07927-y
125. Liu H, Zhang H, Wu X, Ma D, Wu J, Wang L, et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature (2018) 563:131–6. doi: 10.1038/s41586-018-0629-6
126. Choudhuri S, Garg NJ. PARP1-cGAS-NFkB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease. PLoS Pathog (2019) 16(4):e1008474. doi: 10.1371/journal.ppat.1008474
127. Di Paolo NC, Doronin K, Baldwin LK, Papayannopoulou T, Shayakhmetov DM. The transcription factor IRF3 triggers “defensive suicide” necrosis in response to viral and bacterial pathogens. Cell Rep (2013) 3:1840–6. doi: 10.1016/j.celrep.2013.05.025
128. Anghelina D, Lam E, Falck-Pedersen E. Diminished innate antiviral response to adenovirus vectors in cGAS/STING-deficient mice minimally impacts adaptive immunity. J Virol (2016) 90:5915–27. doi: 10.1128/JVI.00500-16
129. Liu S, Cai X, Wu J, Cong Q, Chen X, Li T, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science (2015) 347:aaa2630. doi: 10.1126/science.aaa2630
130. Tanaka Y, Chen ZJ. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal (2012) 5:ra20. doi: 10.1126/scisignal.2002521
131. Prabakaran T, Bodda C, Krapp C, Zhang BC, Christensen MH, Sun C, et al. Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J (2018) 37:e97858. doi: 10.15252/embj.201797858
132. Saxton RA, Sabatini DM. mTOR Signaling in growth, metabolism, and disease. Cell (2017) 168:960–76. doi: 10.1016/j.cell.2017.02.004
133. Hasan M, Gonugunta VK, Dobbs N, Ali A, Palchik G, Calvaruso MA, et al. Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism. Proc Natl Acad Sci USA (2017) 114:746–51. doi: 10.1073/pnas.1611113114
134. Liang Q, Seo GJ, Choi YJ, Kwak MJ, Ge J, Rodgers MA, et al. Crosstalk between the cGAS DNA sensor and Beclin-1 autophagy protein shapes innate antimicrobial immune responses. Cell Host Microbe (2014) 15:228–38. doi: 10.1016/j.chom.2014.01.009
135. Sliter DA, Martinez J, Hao L, Chen X, Sun N, Fischer TD, et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature (2018) 561:258–62. doi: 10.1038/s41586-018-0448-9
136. Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell (2012) 150:803–15. doi: 10.1016/j.cell.2012.06.040
137. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 458:762–5. doi: 10.1038/nature07823
138. Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P. miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet (2010) 6:e1000795. doi: 10.1371/journal.pgen.1000795
139. Aoi W, Naito Y, Mizushima K, Takanami Y, Kawai Y, Ichikawa H, et al. The microRNA miR-696 regulates PGC-1{alpha} in mouse skeletal muscle in response to physical activity. Am J Physiol Endocrinol Metab (2010) 298:E799–806. doi: 10.1152/ajpendo.00448.2009
140. Rouault TA, Tong WH. Iron-sulfur cluster biogenesis and human disease. Trends Genet (2008) 24:398–407. doi: 10.1016/j.tig.2008.05.008
141. Zhang X, Ji R, Liao X, Castillero E, Kennel PJ, Brunjes DL, et al. MicroRNA-195 regulates metabolism in failing myocardium via alterations in Sirtuin 3 expression and mitochondrial protein acetylation. Circulation (2018) 137:2052–67. doi: 10.1161/CIRCULATIONAHA.117.030486
142. Yan K, An T, Zhai M, Huang Y, Wang Q, Wang Y, et al. Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2. Cell Death Dis (2019) 10:500. doi: 10.1038/s41419-019-1734-7
143. Wang K, Gan TY, Li N, Liu CY, Zhou LY, Gao JN, et al. Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Diff (2017) 24:1111–20. doi: 10.1038/cdd.2017.61
144. Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, et al. Targeting Mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output. Cell (2020) 183:76–93.e22. doi: 10.1016/j.cell.2020.08.009
145. Wu Z, Sun H, Wang C, Liu W, Liu M, Zhu Y, et al. Mitochondrial genome-derived circRNA mc-COX2 functions as an oncogene in chronic lymphocytic leukemia. Mol Ther Nucleic Acids (2020) 20:801–11. doi: 10.1016/j.omtn.2020.04.017
146. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature (2012) 489:101–8. doi: 10.1038/nature11233
147. Rackham O, Shearwood AM, Mercer TR, Davies SM, Mattick JS, Filipovska A. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA (2011) 17:2085–93. doi: 10.1261/rna.029405.111
148. Sirey TM, Roberts K, Haerty W, Bedoya-Reina O, Rogatti-Granados S, Tan JY, et al. The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity. Elife (2019) 8:e45051. doi: 10.7554/eLife.50980
149. Long J, Badal SS, Ye Z, Wang Y, Ayanga BA, Galvan DL, et al. Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. J Clin Invest (2016) 126:4205–18. doi: 10.1172/JCI87927
150. Chen G, Guo H, Song Y, Chang H, Wang S, Zhang M, et al. Long noncoding RNA AK055347 is upregulated in patients with atrial fibrillation and regulates mitochondrial energy production in myocardiocytes. Mol Med Rep (2016) 14:5311–7. doi: 10.3892/mmr.2016.5893
151. Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun (2014) 5:3596. doi: 10.1038/ncomms4596
Keywords: mitochondria, metabolism, macrophage, innate immunity, cGAS-STING, mitophagy, noncoding RNA
Citation: Choudhuri S, Chowdhury IH and Garg NJ (2021) Mitochondrial Regulation of Macrophage Response Against Pathogens. Front. Immunol. 11:622602. doi: 10.3389/fimmu.2020.622602
Received: 28 October 2020; Accepted: 29 December 2020;
Published: 17 February 2021.
Edited by:
Pedro Manoel Mendes Moraes Vieira, Campinas State University, BrazilReviewed by:
Albert Descoteaux, Université du Québec, CanadaRobert A. Harris, University of Kansas Medical Center, United States
Copyright © 2021 Choudhuri, Chowdhury and Garg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nisha Jain Garg, bmlnYXJnQHV0bWIuZWR1